- Report
- May 2024
- 200 Pages
Global
From €3770EUR$4,150USD£3,215GBP
- Report
- May 2023
- 140 Pages
Global
From €4495EUR$4,949USD£3,834GBP
- Report
- July 2024
- 130 Pages
Global
From €4042EUR$4,450USD£3,447GBP
- Report
- June 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,757GBP
- Report
- June 2023
- 99 Pages
Global
From €4088EUR$4,500USD£3,486GBP
- Report
- November 2023
- 90 Pages
Global
From €3500EUR$4,128USD£3,089GBP
From €117EUR$129USD£100GBP
The Stem Cell Source market is a subset of the larger stem cell industry. It is focused on the production and distribution of stem cells for research and therapeutic purposes. Stem cells are derived from a variety of sources, including embryonic, adult, and induced pluripotent stem cells. These cells are used in a variety of applications, including regenerative medicine, drug discovery, and tissue engineering.
The Stem Cell Source market is highly competitive, with a number of companies offering a wide range of products and services. Companies in the market include Cellular Dynamics International, Stem Cell Technologies, STEMCELL Technologies, and Thermo Fisher Scientific. These companies provide a range of products and services, including stem cell lines, media, reagents, and services such as cell banking and cryopreservation. Show Less Read more
